- Research article
- Open Access
- Open Peer Review
Derivation and assessment of risk prediction models using case-cohort data
- Jean Sanderson^{1},
- Simon G Thompson^{1},
- Ian R White^{2},
- Thor Aspelund^{3, 4} and
- Lisa Pennells^{1}Email author
https://doi.org/10.1186/1471-2288-13-113
© Sanderson et al.; licensee BioMed Central Ltd. 2013
- Received: 16 January 2013
- Accepted: 9 September 2013
- Published: 13 September 2013
Abstract
Background
Case-cohort studies are increasingly used to quantify the association of novel factors with disease risk. Conventional measures of predictive ability need modification for this design. We show how Harrell’s C-index, Royston’s D, and the category-based and continuous versions of the net reclassification index (NRI) can be adapted.
Methods
We simulated full cohort and case-cohort data, with sampling fractions ranging from 1% to 90%, using covariates from a cohort study of coronary heart disease, and two incidence rates. We then compared the accuracy and precision of the proposed risk prediction metrics.
Results
The C-index and D must be weighted in order to obtain unbiased results. The NRI does not need modification, provided that the relevant non-subcohort cases are excluded from the calculation. The empirical standard errors across simulations were consistent with analytical standard errors for the C-index and D but not for the NRI. Good relative efficiency of the prediction metrics was observed in our examples, provided the sampling fraction was above 40% for the C-index, 60% for D, or 30% for the NRI. Stata code is made available.
Conclusions
Case-cohort designs can be used to provide unbiased estimates of the C-index, D measure and NRI.
Keywords
- Case-cohort
- Risk prediction
- Discrimination
- Reclassification
- Cardiovascular disease
Background
The case-cohort sampling design, initially introduced by Prentice [1], reduces the amount of data collection required compared to full cohort studies by efficient sampling of the non-diseased individuals. Information is collected on a random sample of the original cohort (the subcohort) as well as all additional cases. Together, the subcohort and the extra cases form the case-cohort set. Although follow-up for disease is still necessary for the full cohort, covariate information (which is often costly to obtain) is only required for the case-cohort set. Furthermore, if the subcohort is chosen at random (i.e. an unstratified design) then it can be used as a comparison group for multiple diseases of interest, offering an advantage over the nested case–control design. Hazard ratios for case-cohort studies are typically estimated using a weighted version of the Cox proportional hazards model [1]. Different weighting methods have been proposed and these methods are well documented in the literature [2]. Similarly, the baseline hazard can be estimated using a weighted version of the standard Breslow estimator, allowing estimation of absolute risks.
Although investigation of the bias in resulting hazard ratio estimates has been the subject of previous research [3], there has been little work on the accuracy and precision of risk predictions made using a model in which both the hazard ratios and baseline survival estimates have been derived using case-cohort data. Measures to quantify the predictive ability of risk models have been adapted and applied to case-cohort designs by Ganna et al [4] who describe the use of the C-index, reclassification and calibration for both stratified and unstratified case-cohort designs.
Time-dependent area under the ROC curve methods [5] have also been used in the case-cohort setting [6, 7] and C-statistics and the net reclassification index (NRI) have been applied by Vaarhorst et al [8]. However, any resulting bias in the estimates and their standard errors (SEs) has not been extensively investigated and the use of other measures of predictive ability has so far, to our knowledge, not been considered. The use of predictive measures in case-cohort designs is of increasing relevance, as technological advances permit routine measurement of many novel biological and genomic markers for risk prediction. Large studies with various disease outcomes can be utilised efficiently by adopting a case-cohort design [9].
In this paper we describe methods for deriving risk prediction models from case-cohort data and focus on relevant adaptation of commonly used measures to assess their predictive ability: Harrell’s C [10, 11], Royston and Sauerbrei’s D [12], and the NRI [13, 14]. The proposed methods are extensively assessed through simulation, in which estimates from case-cohort data are compared to those which would have been seen in a full cohort study.
Methods and results
Data and simulations used
Descriptive statistics and hazard ratios of CHD in the Reykjavik prospective cohort study
Hazard ratio (95% CI) for CHD per 1 standard deviation higher value or in comparison with reference category* | |||
---|---|---|---|
Mean (SD) or n (%) | Model 1 | Model 2 | |
Age at survey (years) | 52.3 (7.6) | 1.68 (1.60, 1.77) | 1.65 (1.57, 1.74) |
Smoking status (smoker vs non-smoker)* | 3,609 (53.3) | 1.54 (1.40, 1.70) | 1.51 (1.37, 1.66) |
Systolic blood pressure (mmHg) | 141.8 (20.6) | 1.22 (1.17, 1.28) | 1.22 (1.17, 1.28) |
Total cholesterol (mmol/l) | 6.3 (1.0) | 1.31 (1.26, 1.37) | 1.27 (1.22, 1.33) |
HDL-cholesterol (mmol/l) | 1.4 (0.2) | 0.80 (0.76, 0.85) |
where $\widehat{\mathbf{\beta}}{\mathbf{x}}_{i}$ is the linear predictor of each individual, $\widehat{\gamma}$ is the Weibull shape parameter, and U _{ i } is a randomly generated Uniform (0,1) variable. Staggered entry was imposed, permitting individuals to enter the study randomly between 0 and 5 years, and event times were censored at 25 years.
Our simulation procedure, designed to test the effectiveness of case-cohort methods compared to those utilising the full cohort, is as follows: 1) A new realisation of the full cohort is generated by simulating new outcome data as described above. In the simulated full cohort we derive a CHD risk prediction model, and calculate subsequent measures of predictive ability, thereby providing a “gold standard” to which results achieved with case-cohort samples can be compared. 2) A random subsample of the full cohort, with proportion α, and all the CHD cases, are selected to form the case-cohort set. The prediction model and appropriate measures of interest are then calculated in this subsample using case-cohort methods (described in later sections). This procedure (both steps 1 and 2) is repeated 1000 times for each of 18 choices of sampling fraction, α, with values 0.01, 0.02, … 0.1, 0.2, … 0.9.
Deriving a risk prediction model using case-cohort data
where t represents time from study entry, S(t|x) is the probability of surviving beyond time t given covariates x and S _{0}(t) is the baseline survival function at time t. The vector β = (β _{1}, β _{2}, ⋯, β _{ p }) represents the multivariable adjusted log hazard ratios (HRs) per unit increase in the risk predictors ${\mathbf{x}}_{i}^{T}={\left({x}_{i1},{x}_{i2},\cdots ,{x}_{\mathit{ip}}\right)}^{T}$. An individual’s estimated linear predictor is $\widehat{\mathbf{\beta}}{\mathbf{x}}_{i}$ $={\displaystyle \sum _{j}{\widehat{\beta}}_{j}}{x}_{\mathit{ij}}$ and their estimated absolute risk of experiencing an event by time t is 1– ${\widehat{S}}_{0}{\left(t\right)}^{exp\left(\widehat{\beta}{x}_{i}\right)}$. Due to the over-representation of cases in the case-cohort design, two adaptations are needed in risk model derivation as follows.
Estimating hazard ratios from case-cohort data
With case-cohort data a pseudolikelihood is used to estimate $\widehat{\mathbf{\beta}}$ from a weighted Cox regression, with cases outside the subcohort not considered ‘at risk’ until immediately before their event. Three commonly used weighting methods have been proposed: Prentice [1], Self & Prentice [17], and Barlow [2]. The Prentice and Self & Prentice methods differ only in the contribution of a non-subcohort case at the time of their event: with the Self & Prentice formulation only subcohort individuals are included in the risk set. The Barlow weighting scheme takes a different approach, weighting the subcohort controls and future cases by the inverse of the subcohort sampling fraction. This aims to mimic the proportions that would have been present in the full cohort analysis. These weighting methods have been previously described in detail and compared by simulation. The methods were shown to provide similar results with the Prentice method generally being preferred for small subcohort sizes [3].
The usual SE estimates for the CPH model are not valid in the case-cohort situation. A robust jackknife estimator was proposed [2] and can be implemented in most standard software. (Although the SE itself is not necessary for risk estimation, it may be influential in choice of risk predictors to include in the risk model).
Estimating baseline hazard from case-cohort data
In order to provide absolute risk predictions it is necessary to estimate the baseline survival function, S _{0}(t). For case-cohort data this is achieved via a weighted version of the Breslow estimator of the cumulative baseline hazard [17, 18]. This additional weighting applies to the Prentice and Self & Prentice weighting methods but not Barlow. The Barlow method mimics the proportions observed in the full cohort sample and so can be used for the estimation of absolute risk without any further rescaling [19].
Example: Absolute predictions using models derived with case-cohort data
On average the absolute risk tends to be overestimated at low subcohort sampling fractions, and the variability at low subcohort sampling fractions is also greater. Overall the three weighting methods provide very similar estimates of absolute risk (as evidenced by overlapping lines in Figure 1), although at very low sampling fractions the Prentice method is slightly more accurate. This is reflected by slightly more accurate estimates in both the baseline hazard and the log hazard ratios (Additional file 1: Figure S1 and Additional file 1: Figure S2) and concurs with previous findings [3]. Since the different weighting methods show little difference in terms of the resulting risk predictions, further results are presented based on the Prentice scheme only.
Measures of predictive ability
We describe three measures of predictive ability: Harrell’s C-index [10, 11], Royston and Sauerbrei’s D [12], and the net reclassification index (NRI) [13, 14]. Although many other measures exist [20–22], these were selected because of their relevance and familiarity for the intended clinical and epidemiological audience. Adaptations for case-cohort data deal with the over-representation of cases compared to the original cohort design. Application of standard measures of predictive ability without considering the sampling of the data will result in bias.
C-index for case-cohort designs
where n _{ r } = n _{ c } + n _{ d } + n _{ u } is the total number of relevant pairs. A C-index value of 0.5 indicates no discriminative ability, beyond that of chance, and 1 indicates perfect discrimination.
where n _{ i,j } represents the number of pairs in group i = concordant, discordant or uncertain, and j = 0 (case–control comparisons) or 1 (case-case comparisons). This can be implemented in Stata using the somersd [23] function with importance weights, which also gives an appropriately weighted standard error.
D for case-cohort designs
With full cohort data, Royston and Sauerbrei’s D is calculated by firstly transforming linear predictors ($\widehat{\mathbf{\beta}}{\mathbf{x}}_{i}$) to give standard normal order rank statistics (using Blom’s approximation). The rank statistics are multiplied by $\sqrt{\pi /8}$ to give z _{ i } for i = 1…n subjects. A second CPH model is then fitted to these values and the value of D is given by the coefficient of z in this second model. The distribution of z is approximately N(0, π/8) and has the property that the mean of the negative and positive z values are −0.5 and 0.5. D can therefore be interpreted as the log hazard ratio between the participants at higher risk versus those at lower risk. The SE of D is given by the SE of the coefficient of z.
In order to estimate D in the case-cohort design, we propose a novel weighted D measure. We assume $\widehat{\mathbf{\beta}}$ has been estimated using the weighted Cox regression described earlier, and apply the following adaptations:
1) Since controls are under-represented in the case-cohort set, the normal order rank statistics are formed using a modification that emulates the values that would have been obtained using the full cohort data: i) the “weighted ranks” are formed by applying an increased weight of 1/α to the subcohort controls; ii) the weighted normal order rank statistics are formed using Blom’s approximation, where the sample size is taken to be the maximum weighted rank (approximating the number in the full cohort); iii) as with the full cohort method, the weighted normal order rank statistics are then multiplied by $\sqrt{\pi /8}$ to give ${z}_{i}^{C}$.
2) A weighted CPH model is fitted to the ${z}_{i}^{C}$ (using any of the three weighting methods described earlier). Our case-cohort weighted estimate, D _{ W }, is given by the coefficient of z ^{ C } in this model and its SE is given as the SE of the coefficient of z ^{ C }. As with estimating the hazard ratios, a robust variance estimator should be specified to obtain the appropriate SEs.
Example: Measures of discrimination calculated using case-cohort data
Figure 2b shows the weighted case-cohort estimates only, along with the empirical 95% CI. As would be expected, the CI width of the adapted measures is greater at lower sampling fractions, and approaches that of the full cohort estimate as subcohort sampling fraction increases. The mean analytical SE agrees well with the empirical SE (over the 1000 simulations at each subcohort sampling fraction) as shown in Additional file 1: Figure S3.
Net reclassification improvement (NRI) for case-cohort designs
One limitation of the NRI is that it is heavily dependent on the specified risk categories. Pencina et al [14] recommend that this NRI measure should only be used if categories are already established in the field of application and influence care decisions. They also propose a continuous version of the NRI that does not require the pre-definition of risk categories, and can therefore be applied universally [14]. The continuous NRI is estimated by classifying individuals based on the direction of any change in predicted risk, regardless of magnitude.
In estimating the NRI in case-cohort designs it is necessary to consider the effect of censoring the observations that have had an event after t years. In the implementation for cohort designs, when using t year absolute risk, individuals who had an event after this time are censored and so count in the non-events category. For case-cohort designs this should apply only to cases in the subcohort. Cases outside the subcohort that experience an event after t years should be excluded from the calculation. If this exclusion does not occur, then the predicted absolute risk among non-cases will be artificially high, being biased by over-representation of participants who will become cases after t years. This modification was not implemented by Ganna et al [4], but would be of less relevance due to the comparatively short follow-up time of the study they consider.
Since the probabilities of movement are evaluated separately for events and non-events, the over-representation of cases in the design does not impact the NRI in the same way as the discrimination metrics and no additional weighting to Equation (5) (or the standard error proposed by Pencina et al [13]) is required. Ganna et al [4] propose a weighted version of the NRI, but this weighting is not necessary for unstratified designs.
An alternative formulation of the NRI for case-cohort designs, in which it is not necessary to exclude the non-subcohort cases that occur after t years, is also possible. Under this strategy, the additional individuals are included in the non-event portion of the calculation, and to compensate for the over-representation of cases a weighting of 1/α is applied to the subcohort controls. The non-event portion of the calculation then includes three distinct groups; subcohort and non-subcohort cases that occur after t years (both with weight 1) and subcohort controls (with weight 1/α). While we do not present results for this approach, it potentially provides estimates with lower variance due to the inclusion of additional information.
Example: Measures of reclassification calculated using case-cohort data
The category-based NRI shows a small amount of bias and larger variability at low subcohort sampling fractions but this reduces as the sampling fraction increases. The continuous NRI appears unbiased even at low sampling fractions. However, as shown in Additional file 1: Figure S4, when the component fractions for cases and controls are considered separately, a small amount of bias is seen in each term. The observed bias can be attributed to bias in the initial 10-year risk predictions obtained using the prediction model derived from case-cohort rather than full cohort data. The increased variance is primarily attributed to the non-event NRI portion of the calculation in Equation 5 since this is calculated using only a subsample of the non-events in the full cohort (Additional file 1: Figure S4). The number of events at 10 years will be the same in the case-cohort sample, as in the full cohort, so this portion of the calculation remains effectively the same.
The analytical SE of the NRI underestimates the empirical SE (Additional file 1: Figure S5). This may be because the analytical SE does not account for potential error in the absolute risk estimates. As shown in Figure 1, the absolute risk predictions show a small amount of bias at low subcohort sampling fractions, and also greater variability. This leads to a larger variability in the resulting NRI estimates than implied by the analytical formula for the SE. This is confirmed by noting that when the case-cohort NRI is estimated using the absolute risks generated from the whole cohort sample (and therefore without bias) the discrepancy does not occur. Instead the empirical SE is greatly reduced and shows good agreement with the analytical estimate. The difference between analytical and empirical SE is also not as marked for the continuous NRI. This is because movement is defined as any change in predicted risk, and so any bias in the absolute risk predictions is less likely to affect the overall proportions of individuals moving up and down than for the category-based measure, where small biases in the overall absolute risk can make large differences to the amount of movement between categories.
Extended simulations: impact of incidence
In practice, very small subcohort sampling fractions would only be utilised in a study with a low incidence rate. So, our simulation procedure is replicated here for another example with a reduced incidence rate. The reduction in incidence rate is achieved by halving the Weibull rate parameter used to generate the event times in Equation (1). For this second example, the mean 10-year incidence is 0.027, as opposed to the original mean incidence of 0.073.
Results of simulation study with alternative incidence rates
a) Discrimination measures | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incidence* 10 years (25 years) | Sampling fraction | % Cases (25 years) | Harrell’s C | Royston and saubrei’s D | ||||||||||||
Full cohort | Case-cohort | Full cohort | Case-cohort | |||||||||||||
UW (bias %) | W | SE | ESE** | RE^{‡} | ERE^{‡‡} | UW (bias %) | W | SE | ESE** | RE^{‡} | ERE^{‡‡} | |||||
0.073 (0.277) | 0.03 | 91 | 0.674 | 0.552 (18.1) | 0.675 | 0.018 | 0.018 | 0.135 | 0.126 | 1.060 | 0.336 (68.3) | 1.099 | 0.162 | 0.172 | 0.064 | 0.055 |
0.1 | 76 | 0.591 (12.4) | 0.675 | 0.011 | 0.011 | 0.354 | 0.349 | 0.568 (46.5) | 1.070 | 0.094 | 0.092 | 0.192 | 0.197 | |||
0.3 | 52 | 0.637 (5.5) | 0.674 | 0.008 | 0.008 | 0.678 | 0.672 | 0.832 (21.4) | 1.063 | 0.060 | 0.057 | 0.474 | 0.479 | |||
0.5 | 39 | 0.655 (2.7) | 0.674 | 0.007 | 0.007 | 0.831 | 0.817 | 0.942 (11.0) | 1.060 | 0.050 | 0.047 | 0.671 | 0.682 | |||
0.9 | 26 | 0.672 (0.3) | 0.675 | 0.007 | 0.006 | 0.978 | 0.981 | 1.046 (1.4) | 1.061 | 0.043 | 0.040 | 0.933 | 0.935 | |||
0.027 (0.112) | 0.03 | 76 | 0.679 | 0.576 (15.3) | 0.681 | 0.021 | 0.020 | 0.283 | 0.288 | 1.073 | 0.491 (54.4) | 1.087 | 0.173 | 0.167 | 0.147 | 0.157 |
0.1 | 49 | 0.627 (7.6) | 0.679 | 0.014 | 0.014 | 0.582 | 0.580 | 0.771 (28.1) | 1.072 | 0.109 | 0.102 | 0.368 | 0.4179 | |||
0.3 | 24 | 0.662 (2.5) | 0.679 | 0.012 | 0.011 | 0.843 | 0.862 | 0.970 (9.4) | 1.073 | 0.080 | 0.075 | 0.682 | 0.7407 | |||
0.5 | 16 | 0.671 (1.1) | 0.679 | 0.011 | 0.011 | 0.926 | 0.928 | 1.023 (4.3) | 1.069 | 0.073 | 0.07 | 0.823 | 0.8868 | |||
0.9 | 10 | 0.679 (0.1) | 0.680 | 0.011 | 0.011 | 0.991 | 0.997 | 1.070 (0.5) | 1.076 | 0.068 | 0.066 | 0.956 | 0.9835 | |||
b) NRI | ||||||||||||||||
Incidence* 10 years (25 years) | Sampling fraction | % Cases (25 years) | Category-based NRI | Continuous NRI | ||||||||||||
Full cohort | Case-cohort | Full cohort | Case-cohort | |||||||||||||
NRI | SE | ESE** | RE ^{ ‡ } | ERE ^{ ‡‡ } | NRI | SE | ESE** | RE ^{ ‡ } | ERE ^{ ‡‡ } | |||||||
0.073 (0.277) | 0.03 | 97 | 0.028 | 0.029 | 0.025 | 0.033 | 0.414 | 0.265 | 0.170 | 0.166 | 0.086 | 0.095 | 0.296 | 0.214 | ||
0.1 | 86 | 0.028 | 0.019 | 0.023 | 0.713 | 0.506 | 0.170 | 0.060 | 0.069 | 0.602 | 0.490 | |||||
0.3 | 76 | 0.027 | 0.017 | 0.018 | 0.906 | 0.798 | 0.169 | 0.050 | 0.051 | 0.854 | 0.753 | |||||
0.5 | 52 | 0.028 | 0.017 | 0.018 | 0.960 | 0.814 | 0.171 | 0.048 | 0.050 | 0.932 | 0.898 | |||||
0.9 | 26 | 0.028 | 0.016 | 0.018 | 0.997 | 0.963 | 0.170 | 0.047 | 0.046 | 0.992 | 0.981 | |||||
0.027 (0.112) | 0.03 | 91 | 0.011 | 0.015 | 0.014 | 0.022 | 0.571 | 0.308 | 0.156 | 0.154 | 0.106 | 0.114 | 0.561 | 0.456 | ||
0.1 | 66 | 0.012 | 0.012 | 0.015 | 0.813 | 0.603 | 0.160 | 0.087 | 0.096 | 0.822 | 0.730 | |||||
0.3 | 49 | 0.010 | 0.011 | 0.012 | 0.954 | 0.965 | 0.156 | 0.081 | 0.080 | 0.947 | 0.903 | |||||
0.5 | 24 | 0.011 | 0.011 | 0.013 | 0.990 | 0.933 | 0.160 | 0.080 | 0.083 | 0.976 | 0.959 | |||||
0.9 | 10 | 0.011 | 0.011 | 0.012 | 1.008 | 0.944 | 0.155 | 0.079 | 0.076 | 0.997 | 0.978 |
As described previously, the unweighted discrimination measures are biased. For a given sampling fraction the bias is less pronounced for the lower incidence rate as the over-representation of cases is less extreme. The relative efficiency for discrimination and the NRI is also more favourable for the lower incidence rate. As would be expected, as the incidence rate increases, a larger subcohort sampling fraction is required in order to maintain the same efficiency compared to the full cohort.
Discussion
We have described methods to derive and assess the predictive ability of risk models using case-cohort data. The derived risk prediction models were shown to give slightly elevated and more variable risk predictions at small subcohort sampling fractions, but otherwise were comparable with those which might be achieved in full cohort data. We have demonstrated that failure to account for case-cohort sampling can lead to biased results when assessing predictive ability, and have adapted three measures of predictive ability that then give results comparable to that which would be obtained with full cohort data. The following Stata [24] commands to implement these methods are available at http://www.phpc.cam.ac.uk/ceu/research/erfc/stata: ‘mvmetaipd’, which can be used to fit prediction models, and ‘predaddc’, ‘predaddd’ and ‘predstat’ which can be used to estimate the C-index, D measure and NRI respectively. These commands can be applied with cohort data, case-cohort data, and single or multiple studies according to the options selected.
For both Harrell’s C and Royston and Sauerbrei’s D the standard methods return lower estimates when applied to case-cohort designs than when applied to the full cohort data set. For Harrell’s C, this bias arises because of the over-representation of case-case pairs, which are less likely to be concordant than case–control pairs. For Royston and Sauerbrei’s D, bias arises as the overall risk is inflated due to the inclusion of extra cases, leading to reduced separation between those at low and high predicated risk. The magnitude of the bias is dependent on the subcohort sampling fraction, with the bias increasing as the subcohort sampling fraction decreases (and hence the enrichment of cases in the data set increases).
Applying a weighted version of these discrimination measures provides estimates similar to that which would have been expected in the full cohort. This weighting should also be applied when assessing the changes in the C-index or D on addition of a new marker. Failure to weight the measures of predictive ability for each model could lead to an underestimation of the change in predictive ability. A small amount of bias remains with the weighted version of D at low subcohort sampling fractions, which may be due to the fact it is estimated as the coefficient from a weighted Cox model. When applying such weighted Cox models in the initial risk model derivation, we found similar slight bias.
Another important consideration is the possibility of overfitting at low subcohort sampling fractions, leading to inflated discrimination metrics. In the results provided, the bias seen at low subcohort sampling fractions is greater for D than for the C-index. If this bias was due to overfitting in estimation of the risk model then we would expect this effect to be observed for both C and D and so we conclude that this bias is introduced due to the procedure for estimating D rather than overfitting. In assessing bias our gold standard was evaluation of the full-cohort model in the full cohort. Hence, bias can arise both from differences in the fitted model (possibly overfitting) and in the calculation of prediction metrics. A reviewer has correctly pointed out that an additional comparison, which would allow isolation of error due to differences in the fitted model, would be evaluation of the case-cohort model in the full cohort; we suggest that yet another comparison would be evaluation in an independent cohort. However, our results show that the weighted evaluations agree closely with our gold standard; there is little bias to explain, suggesting that our gold standard was adequate in these large samples. Although it is not of concern in our example due to the relatively large sample size of the original cohort, the possibility of overfitting is an important consideration when analysing smaller case-cohort studies with low subcohort sampling fractions.
For the NRI, no adaptation to the standard calculations is required but individuals who experienced an event after the chosen cut-off at t years must be excluded from the calculation unless they belong to the subcohort. Application of both the category-based and continuous NRI was considered, with less bias observed at small sampling fractions for the continuous NRI.
The results of the simulation studies at two choices of incidence rate provide guidance on the efficiency of the described case-cohort weighted methods. For data with the same properties (i.e. full cohort size, follow-up and incidence) as the Reykjavik study, the relative efficiency of the prediction metrics for the case-cohort design was close to that of the full cohort (based on 75% efficiency, Figure 4) provided that the subcohort sampling fraction was above 40% for the C-index, 60% for the D measure or 30% for the NRI. This is greater than the subcohort sampling fraction, of around 10%, found by Onland-Moret et al [3] to be necessary to achieve reasonable accuracy and precision in coefficients alone. For the C-index and D measure the generated analytical SEs were very similar to the corresponding empirical estimates. However this was not the case for the NRI, for which the analytical SE was lower. The NRI relies on absolute risk predictions, which themselves are subject to some bias and extra variability when estimated using case-cohort data. Small changes in absolute risk predictions can greatly affect risk categorisation and we believe this to be the origin of the extra empirical variation. This is not as relevant for D and the C-index, which rely only on comparing ranks of the linear predictor, and is less of an issue with the continuous NRI which does not rely on categorising predicted absolute risk. We conclude that analytical SEs may not be appropriate for the NRI calculated from case-cohort designs and recommend that SEs should instead be computed by bootstrapping. The relative efficiency for all measures investigated is shown to be more favourable for the lower incidence rate.
Extension to the multi-study setting is also possible, using the methods described elsewhere [25, 26]. This applies when combing multiple studies each with a case-cohort design, but also when combining studies of different designs. The risk prediction model can be derived using a (weighted) CPH model stratified by study and, if applicable, sex, producing one set of coefficients over all studies. If the Breslow weighting method is applied, different subcohort sampling fractions may be specified for each study. Similarly, in order to estimate absolute risks the weighting applied to the Breslow estimator may vary by study. To pool study-specific estimates of predictive ability in the case of full cohort data, it has been suggested to weight by the number of events in each study [25, 26]. This choice is also intuitively appealing for case-cohort designs, although other methods may be appropriate if pooling across case-cohort studies with a large amount of heterogeneity in the subcohort sampling fraction.
The presented simulations are based on real data, giving the advantage of representing the properties (e.g. distributions and associations between covariates) of typical epidemiological studies. However, in order to provide results that are generalisable to wider application, two choices of incidence rate were considered. Another factor that affects the observed results is the size of the initial cohort study. For a larger starting cohort size, the results at a given subcohort sampling fraction will have lower variance.
The C-index is slightly sensitive to random censoring [27], and the presented NRI calculation excludes individuals censored before the time point of interest. Our focus was to contrast results using the proposed measures for case-cohort data to those which would have been seen in original (censored) cohort data, and we have shown the two to be comparable. They remain comparable for two different incidence rates (which induce different degrees of censoring). The implication of this is that the estimates of predictive ability made using case-cohort data will be similarly subject to censoring induced bias as are full cohort estimates.
We have not considered competing risks in our proposed methods and simulations, which will be important for example when predicting lifetime risks. If competing risks are included when estimating risk then further adaptation of measures of discrimination are necessary [28]. Likewise, if non-proportional hazards are modelled, if time dependant covariates are included, or if age rather than time from study entry is used as the time scale, then the ranking of $\widehat{\mathbf{\beta}}{\mathbf{x}}_{i}$ can change with time. Calculation of measures of discrimination in such instances is a matter for further research. Competing risks are unlikely to make a substantial difference when making 10-year CHD risk predictions for our example participants, who are mostly under the age of 60 (Table 1).
Conclusions
In summary, this paper provides a thorough description of the issues related to deriving and assessing predictive ability in case-cohort studies. With the increasing use of case-cohort designs to answer questions relating to risk prediction, the methods presented in this paper will enable suitable measures of predictive ability to be computed and compared with studies of other designs.
Declarations
Acknowledgements
We thank the Reykjavik study for provision of data on which simulations were based, and Dr Stephen Kaptoge for preparing the Stata code referenced in this paper.
Funding
This work was supported by two grants from the UK Medical Research Council [grant numbers G0701619 and G0800270] and grants from the British Heart Foundation [grant number SP/09/002] and European Union [FP7, grant number 2793233–2].
Authors’ Affiliations
References
- Prentince RL: A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986, 73: 1-11. 10.1093/biomet/73.1.1.View ArticleGoogle Scholar
- Barlow WE, Ichikawa L, Rosner D, Izumi S: Analysis of case-cohort designs. J Clin Epidemiol. 1999, 52: 1165-1172. 10.1016/S0895-4356(99)00102-X.View ArticlePubMedGoogle Scholar
- Onland-Moret N, Vandera D, Vanderschouw Y, Buschers W, Elias S, Vangils C, Koerselman J, Roest M, Grobbee D, Peeters P: Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol. 2007, 60: 350-355. 10.1016/j.jclinepi.2006.06.022.View ArticlePubMedGoogle Scholar
- Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E: Risk prediction measures for case-cohort and nested case–control designs: an application to cardiovascular disease. Am J Epidemiol. 2012, 175: 715-724. 10.1093/aje/kwr374.View ArticlePubMedPubMed CentralGoogle Scholar
- Chambless LE, Diao G: Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med. 2006, 25: 3474-3486. 10.1002/sim.2299.View ArticlePubMedGoogle Scholar
- Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Sorlie P, Diao G, et al: An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006, 166: 1368-1373. 10.1001/archinte.166.13.1368.View ArticlePubMedGoogle Scholar
- Herder C, Baumert J, Zierer A, Roden M, Meisinger C, Karakas M, Chambless L, Rathmann W, Peters A, Koenig W, et al: Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One. 2011, 6: e19852-10.1371/journal.pone.0019852.View ArticlePubMedPubMed CentralGoogle Scholar
- Vaarhorst AA, Lu Y, Heijmans BT, Dolle ME, Bohringer S, Putter H, Imholz S, Merry AH, van Greevenbroek MM, Jukema JW, et al: Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort study. Circ Cardiovasc Genet. 2012, 5: 202-209. 10.1161/CIRCGENETICS.111.960708.View ArticlePubMedGoogle Scholar
- Danesh J, Saracci R, Berglund G, Feskens E, Overvad K, Panico S, Thompson S, Fournier A, Clavel-Chapelon F, Canonico M, et al: EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007, 22: 129-141. 10.1007/s10654-006-9096-8.View ArticlePubMedGoogle Scholar
- Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA: Evaluating the yield of medical tests. JAMA. 1982, 247: 2543-2546. 10.1001/jama.1982.03320430047030.View ArticlePubMedGoogle Scholar
- Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.View ArticlePubMedGoogle Scholar
- Royston P, Sauerbrei W: A new measure of prognostic separation in survival data. Stat Med. 2004, 23: 723-748. 10.1002/sim.1621.View ArticlePubMedGoogle Scholar
- Pencina MJ, D’Agostino RB, D’Agostino RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172. 10.1002/sim.2929.View ArticlePubMedGoogle Scholar
- Pencina MJ, D’Agostino RB, Steyerberg EW: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011, 30: 11-21. 10.1002/sim.4085.View ArticlePubMedGoogle Scholar
- Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G: Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk. 2002, 9: 67-76. 10.1097/00043798-200204000-00001.View ArticlePubMedGoogle Scholar
- Cox DR: Regression Models and Life-Tables. J R Stat Soc Ser B Methodol. 1972, 37: 187-220.Google Scholar
- Self SG, Prentice RL: Asymptotic distribution theory and efficiency results for case-cohort studies. Ann Stat. 1988, 16: 64-81. 10.1214/aos/1176350691.View ArticleGoogle Scholar
- Langholz B, Jiao J: Computational methods for case-cohort studies. Comput Stat Data Anal. 2007, 51: 3737-3748. 10.1016/j.csda.2006.12.028.View ArticleGoogle Scholar
- Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K: Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov. 2007, 4: 15-10.1186/1742-5573-4-15.View ArticlePubMedPubMed CentralGoogle Scholar
- Graf E, Schmoor C, Sauerbrei W, Schumacher M: Assessment and comparison of prognostic classification schemes for survival data. Stat Med. 1999, 18: 2529-2545. 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3.0.CO;2-5.View ArticlePubMedGoogle Scholar
- Schemper M, Stare J: Explained variation in survival analysis. Stat Med. 1996, 15: 1999-2012. 10.1002/(SICI)1097-0258(19961015)15:19<1999::AID-SIM353>3.0.CO;2-D.View ArticlePubMedGoogle Scholar
- Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010, 21: 128-138. 10.1097/EDE.0b013e3181c30fb2.View ArticlePubMedPubMed CentralGoogle Scholar
- Newson R: Confidence intervals for rank statistics: Somers’ D and extensions. Stata J. 2006, 6: 309-334.Google Scholar
- Stata Statistical Software: Release 11. 2009, College Station, TX: StataCorp LPGoogle Scholar
- The Emerging Risk Factors Collaboration: Lipid-related markers and cardiovascular disease prediction. JAMA. 2012, 307: 2499-2506.PubMed CentralGoogle Scholar
- The Emerging Risk Factors Collaboration: C-reactive protein, fibrinogen, and cardiovascular disease prediction. NEJM. 2012, 367: 1310-1320.View ArticlePubMed CentralGoogle Scholar
- Gonen M, Heller G: Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005, 92: 965-970. 10.1093/biomet/92.4.965.View ArticleGoogle Scholar
- Wolbers M, Koller MT, Witteman JC, Steyerberg EW: Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009, 20: 555-561. 10.1097/EDE.0b013e3181a39056.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2288/13/113/prepub
Pre-publication history
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.